The Global POLAR program: Two pivotal placebo-controlled studies of calmangafodipir used on top of modified FOLFOX6 to prevent chemotherapy-induced peripheral neuropathy (CIPN) von Lustberg, Maryam B., Pfeiffer, Per, Qvortrup, Camilla, Muro, Kei, Bengtson, Marie Helene, Nittve, Malin, Sonesson, Christian, Nagahama, Fumiko, Sonehara, Yusuke, Carlsson, Carl Stefan

Volltext

The Global POLAR program: Calmangafodipir used on top of modified FOLFOX6 (5-FU/FA and oxaliplatin) to prevent chemotherapy induced peripheral neuropathy (CIPN) von Pfeiffer, Per, Qvortrup, Camilla, Muro, Kei, Lustberg, Maryam B., Nagahama, Fumiko, Sonehara, Yusuke, Bengtson, Marie Helene, Nittve, Malin, Sonesson, Christian, Carlsson, Carl Stefan

Volltext

Persistent prevention of CIPN using calmangafodipir (PledOx): Results from a placebo-controlled randomized phase II study (PLIANT) in patients with metastatic colorectal cancer (mC... von Glimelius, Bengt, Manojlovic, Nebojsa, Pfeiffer, Per, Mosidze, Baadur, Kurteva, Galina Petrova, Karlberg, Mia, Mahalingam, Devalingam, Bengtson, Marie Helene, Nasstrom, Jacques

Volltext